MN
MNYWW
MoneyHero Ltd
$0.0450
-10.00%
$2.0M
No data for this timeframe.
Vol
Market Cap$2.0M
Cap SizeNano Cap
SEC Reports4
Recent Activity
Jun 10, 2026
SEC
MoneyHero Ltd filed a Form 6-K announcing that it will release first quarter 2026 results on June 24, 2026, before marke
6-K — Impact 2/10
May 29, 2026
SEC
MoneyHero Ltd filed a Form 6-K announcing the resignation of Director Rohith Murthy, effective May 26, 2026. The press r
6-K — Impact 2/10
Apr 30, 2026
SEC
MoneyHero reported Q4 2025 net profit of US$0.5 million, its first profitable quarter since listing, with Q4 revenue up
6-K — Impact 6/10
Latest Reports
NEUTRAL
6-K
2/10
MoneyHero Ltd filed a Form 6-K announcing that it will release first quarter 2026 results on June 24, 2026, before marke
Jun 10, 2026
NEUTRAL
6-K
2/10
MoneyHero Ltd filed a Form 6-K announcing the resignation of Director Rohith Murthy, effective May 26, 2026. The press r
May 29, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 3 neutral. Avg impact: 3.3/10.
NEUTRAL
6-K
2/10
MoneyHero Ltd filed a Form 6-K announcing that it will release first quarter 2026 results on June 24
Jun 10, 2026
NEUTRAL
6-K
2/10
MoneyHero Ltd filed a Form 6-K announcing the resignation of Director Rohith Murthy, effective May 2
May 29, 2026
MIXED
6-K
6/10
MoneyHero reported Q4 2025 net profit of US$0.5 million, its first profitable quarter since listing,
Apr 30, 2026
NEUTRAL
6-K
3/10
MoneyHero Ltd announced it will release its fourth quarter and full year 2025 results on April 30, 2
Apr 16, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 19.6% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 22.3% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 16.2% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.